A biotechnology corporation
Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement [Medicare Prescription Drug Savings and Choice Act of 2013, Medicare Prescription Drug Price Negotiation Act of 2013 H.R. 928/H.R. 1102]; issues relating to Prescription Drug User Fee Act and ASP +6; issues related to comparative effectiveness and follow-on biologics, issues related to FDA repeal of Avastin; issues related to coverage of Lucentis and Avastin; H.R. 4438- American Research andCompetitiveness Act of 2014; Issues related to 340B. Trade related issues. Intellectual Property and Process Patent Issues.
MMM - Medicare/Medicaid TRD - Trade (domestic/foreign) CPT - Copyright/Patent/Trademark
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FORBES-TATE
777 6th Street NW, 8th Floor, Washington, DC, 20001, US
JEFFREY FORBES ELIZABETH GREER JERRY DRISCOLL JEFFREY FORBES ELIZABETH GREER JERRY DRISCOLL JEFFREY FORBES ELIZABETH GREER JERRY DRISCOLL